This report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021.
Report : Global Schizophrenia Therapeutics Market 2017-2021 is a new market research publication announced by Reportstack.
Report Outline: Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality.
Although schizophrenia is not as prevalent as other mental disorders, it affects 7 or 8 individuals out of 1,000 people.
Schizophrenic patients are usually diagnosed with low levels of dopamine and serotonin. These are major neurotransmitters in the brain and are responsible for transmitting nerve signals from one neuron to another neuron.
Deficiency of these neurons in the brain leads to impairment of thinking, perception, and the activity of an individual. At present, the treatment regimen for this disease focuses on relieving symptoms.
Thus, antipsychotic drugs are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.
For detailed report with TOC, please click here Global Schizophrenia Therapeutics Market 2017-2021
Market Growth: The global schizophrenia therapeutics market to grow at a CAGR of 1.84% during the period 2017-2021.
• Eli Lilly
• Johnson & Johnson
Other prominent vendors
• Bristol-Myers Squibb
AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Alkermes and Bristol-Myers Squibb.
Category: Market Research Publishers and RetailersCompany profile: Reportstack is one of the largest online libraries of market research publications. At Reportstack, users can find top-level research products from the leading publishers at one place. The best in practice web technology implemented by Reportstack enhances overall user experience and changes the way people buy research reports online. The market coverage spans across multiple verticals including but not limited to: Pharma & Healthcare, Automotive & Transport, Manufacturing & Industry ...
For more information:Make an Inquiry about this report HERE!